Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Brenda Hug
Observed name:
Hug, Brenda
Institution:
Icahn School of Medicine at Mount Sinai
Observed institutions:
Mount Sinai Hospital,
Veterans Health Administration,
VA San Diego Healthcare System,
Icahn School of Medicine at Mount Sinai
ORCID:
0000-0002-9040-808X
Observed ORCID:
0000-0002-9040-808X
OpenAlex ID:
A5061537133
Preclinical validation of a potent γ-secretase modulator for Alzheimer’s disease prevention
2021
·
Kevin D. Rynearson
, Moorthi Ponnusamy
, et al.
·
The Journal of Experimental Medicine
·
88
Clinical utility of tumour‐informed circulating tumour DNA in patients with testicular cancer
2025
·
Reuben Ben‐David
, Ahmed Eraky
, et al.
·
British Journal of Urology
·
13
Bladder Cancer with Undetectable Circulating Tumor DNA After Radical Cystectomy May Be Amenable to a Less Intense Imaging Surveillance Protocol: A Diagnostic Accuracy Study
2025
·
Ahmed Eraky
, Reuben Ben-David
, et al.
·
European Urology Oncology
·
13
Efficacy of Bacillus Calmette-Guérin compared to sequential gemcitabine and docetaxel in Ta high-grade non-muscle invasive bladder cancer
2025
·
Ahmed Eraky
, Brenda Hug
, et al.
·
World Journal of Urology
·
7
Differential response of low- and high-grade intermediate-risk non-muscle-invasive bladder cancer to bacillus Calmette-Guérin and gemcitabine-docetaxel therapy
2025
·
Ahmed Eraky
, Kaushik P. Kolanukuduru
, et al.
·
Urologic Oncology Seminars and Original Investigations
·
7
Diagnostic Accuracy of [ 18 F]-DCFPyL Prostate-Specific Membrane Antigen Positron Emission Tomography/Computerized Tomography in Intermediate-Risk Prostate Cancer Undergoing Radical Prostatectomy: Is Pelvic Lymph Node Dissection Still Necessary?
2025
·
Ahmed Eraky
, Neeraja Tillu
, et al.
·
The Journal of Urology
·
5
Predicting side-specific extraprostatic extension in prostate cancer using an 18F-DCFPyL PSMA-PET/CT–based nomogram
2025
·
Neeraja Tillu
, Ashutosh Maheshwari
, et al.
·
Prostate Cancer and Prostatic Diseases
·
4
Bladder neck involvement in non‐muscle‐invasive bladder cancer: risk implications and outcomes of BCG vs gemcitabine/docetaxel
2025
·
Ahmed Eraky
, Reuben Ben‐David
, et al.
·
British Journal of Urology
·
4
Therapeutic efficacy of Gemcitabine/Docetaxel maintenance in patients with non-muscle-invasive bladder cancer receiving initial Bacillus Calmette-Guérin induction
2026
·
Kaushik P. Kolanukuduru
, Reuben Ben-David
, et al.
·
Urologic Oncology Seminars and Original Investigations
·
1
Ip02-08 Comparative Efficacy of Bcg Induction With Bcg Maintenance Vs. Gemcitabine/docetaxel Maintenance in Patients With Non-muscle-invasive Bladder Cancer
2025
·
Kaushik P. Kolanukuduru
, Reuben Ben-David
, et al.
·
The Journal of Urology
·
1
PDF
Predicting side-specific extraprostatic extension in prostate cancer using an 18F-DCFPyL PSMA-PET/CT-based nomogram
2026
·
Tillu, Neeraja
, Maheshwari, Ashutosh
, et al.
·
Zurich Open Repository and Archive (University of Zurich)
PD37-02 PRECYSTECTOMY ctDNA BURDEN IS PREDICTIVE OF POOR ONCOLOGICAL OUTCOMES
2025
·
Reuben Ben-David
, Ahmed Eraky
, et al.
·
The Journal of Urology
Ip24-36 Undetectable Circulating Tumor Dna Post Radical Cystectomy for Bladder Cancer May Be Amendable to a Less Intense Imaging Surveillance Protocol
2025
·
Ahmed Eraky
, Reuben Ben-David
, et al.
·
The Journal of Urology
PDF
IP02-16 DETECTABLE PRECYSTECTOMY ctDNA STATUS FOR PATIENTS WITH NON-MUSCLE INVASIVE BLADDER CANCER CORRELATES WITH ADVERSE RADICAL CYSTECTOMY OUTCOMES AND POOR PROGNOSIS
2025
·
Reuben Ben-David
, Kaushik P. Kolanukuduru
, et al.
·
The Journal of Urology
Ip02-11 Bacillus Calmette-guérin Versus Sequential Gemcitabine and Docetaxel for Ta High-grade Non-muscle Invasive Bladder Cancer
2025
·
Ahmed Eraky
, Brenda Hug
, et al.
·
The Journal of Urology
PDF
Ip02-09 Comparing Aua Non-muscle-invasive Bladder Cancer Risk Stratification Outcomes: Sequential Gemcitabine and Docetaxel to Bcg
2025
·
Kaushik P. Kolanukuduru
, Ahmed Eraky
, et al.
·
The Journal of Urology
PDF
Ip14-18 Cytomegalovirus Infection Drives Tumor Human Leukocyte Antigen E Expression and Promotes Adaptive Natural Killer Cell Functions in Human Bladder Cancer
2025
·
Brenda Hug
, Igor Duquesne
, et al.
·
The Journal of Urology
PDF
Ip27-16 Comparative Performance of Tumor-informed Circulating Tumor Dna and Imaging Studies in Monitoring Patients With Stage I Testicular Cancer
2025
·
Reuben Ben-David
, Ahmed Eraky
, et al.
·
The Journal of Urology
Ip02-38 Low-grade and High-grade Intermediate-risk Non-muscle-invasive Bladder Cancer Respond Differently to Bacillus Calmette-guerin and Gemcitabine-docetaxel Combination: a Call for Enhanced Risk Stratification
2025
·
Ahmed Eraky
, Kaushik P. Kolanukuduru
, et al.
·
The Journal of Urology
PDF
Use of Induced Pluripotent Stem Cell-Derived Neuronal Disease Models from Patients with Familial Early-Onset Alzheimer’s Disease in Drug Discovery
2022
·
Brenda Hug
, Rudolph E. Tanzi
, et al.
·
Cambridge University Press eBooks
Show more works
View as search
Works count:
20
Citation count:
143
H-index:
5
I10-index:
3
Year
Topic
Type